News

Latest Press Releases

BioPorto Submits Pediatric Application to FDA for The NGAL Test™ Under Breakthrough Designation

First test focused on risk assessment of Acute Kidney Injury in pediatric patients

May 15, 2019

BioPorto Appoints New President of BioPorto Diagnostics, Inc.

Company Plans to Bring Novel Kidney Diagnostic to US Market

April 15, 2019

BioPorto A/S - Annual General Meeting

BioPorto A/S held its Annual General Meeting where the shareholders took note of the report on the Company’s activities and adopted the 2018 Annual Report.

March 18, 2019